Niagen Bioscience (NAGE) Change in Cash (2011 - 2026)

Niagen Bioscience (NAGE) has 16 years of Change in Cash data on file, last reported at $1.8 million in Q1 2026.

• On a quarterly basis, Change in Cash fell 83.93% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $10.9 million, a 61.02% decrease from a year earlier, with the FY2025 full-year figure at $20.1 million, up 16.11% from the prior year.
• Change in Cash for Q1 2026 stood at $1.8 million, up from $498000.0 in the prior quarter.
• Over the last five years, Change in Cash for NAGE reached as high as $12.3 million in Q4 2024 and fell as low as -$7.2 million in Q1 2022.
• Historically, Change in Cash has averaged $2.3 million across 5 years, with a median of $1.8 million in 2026.
• Across the five-year window, Change in Cash plunged 125.81% in 2022 and jumped 4465.0% in 2025, its largest moves.
• Year by year, Change in Cash stood at $7.2 million in 2022, then sank by 92.31% to $552000.0 in 2023, then soared by 2121.38% to $12.3 million in 2024, then sank by 95.94% to $498000.0 in 2025, then surged by 253.61% to $1.8 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $1.8 million in Q1 2026, $498000.0 in Q4 2025, and $3.8 million in Q3 2025.